InMed Pharmaceuticals INM
NASDAQ INM
$1.59 +0.00 (+0.00%)
At close: Aug 20, 2026 · 1:50 PM UTC

InMed Pharmaceuticals (INM) Raw Materials (2022 - 2025)

InMed Pharmaceuticals (INM) posted quarterly Raw Materials of $172200.0 for Q3 2025, down 37.26% year-over-year from $274445.0 in Q3 2024, and down 33.33% quarter-over-quarter from $258300.0 in Q2 2025.

InMed Pharmaceuticals (INM) Raw Materials (2022 - 2025) Analysis & Trends

InMed Pharmaceuticals' Raw Materials history runs 4 years deep, the most recent figure standing at $172200.0 for Q3 2025.

  • In Q3 2025, Raw Materials fell 37.26% year-over-year to $172200.0; the TTM figure through Sep 2025 stood at $172200.0 (down 37.26% YoY), while the FY2025 annual figure was $258300.0, down 30.69% from the prior year.
  • Raw Materials for Q3 2025 stood at $172200.0, down from $258300.0 in the prior quarter.
  • The five-year high for Raw Materials was $387071.0 in Q1 2023, with the low at $172200.0 in Q4 2024.
  • The 4-year median for Raw Materials is $233518.5 (2022), against an average of $250874.9.
  • Peak annual rise in Raw Materials reached 78.55% in 2024, while the deepest fall reached 49.23% in 2024.
  • InMed Pharmaceuticals' Raw Materials stood at $208737.0 in 2022, then changed by 0.0% to $208737.0 in 2023, then decreased by 17.5% to $172200.0 in 2024, then changed by 0.0% to $172200.0 in 2025.
  • Business Quant data shows INM's Raw Materials at $172200.0 in Q3 2025, $258300.0 in Q2 2025, and $258300.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.91 Bn 42.95 Bn -
2 Teva Pharmaceutical Industries 42.98 Bn 39.32 Bn 2.15 Bn
3 Zoetis 31.53 Bn 29.86 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn -
10 InMed Pharmaceuticals 6.44 Mn 1.20 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 172,200.00
Jun 30, 2025 258,300.00
Mar 31, 2025 258,300.00
Dec 31, 2024 172,200.00
Sep 30, 2024 274,445.00
Jun 30, 2024 372,695.00
Mar 31, 2024 196,500.00
Sep 30, 2023 208,737.00
Jun 30, 2023 208,737.00
Mar 31, 2023 387,071.00
Dec 31, 2022 208,737.00
Jun 30, 2022 292,577.00